Biotium reports that GlycoLiner Labelling is fully covalent and compatible with standard fixation and permeabilization protocols
The double-blind, dose-finding ZUPREME-1 trial enrolled 485 adults with overweight or obesity
The FDA nod marks a step forward in precision oncology, linking molecular diagnostics more tightly to therapy selection for advanced prostate cancer
The company is rolling out ARTEMIS, a next-generation AI platform for capsid design
ADX-248, which replaces ADX-743, is being developed for the treatment of metabolic inflammation, including obesity and hypertriglyceridemia
Efdoralprin Alfa was well tolerated, with a safety profile comparable to plasma-derived therapy
Protein L is known as a “superantigen” because it can bind antibodies in unusual ways
Atlas AI combines NVIDIA BioNeMo cloud APIs for intelligent chemical and protein design
Through the collaboration, Lonza will gain access to Singzyme’s enzymatic conjugation platform enabling the site-specific binding of payloads with peptidic linkers to proteins of interest
Arrowhead to receive US $ 120 million upfront payment for Phase 1/2 program for NASH and is eligible to receive potential milestone payments and royalties on commercial sales
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
